Back to search

Article

WNT Signalling Promotes NF-κB Activation and Drug Resistance in KRAS-Mutant Colorectal Cancer

2023-12-23

Abstract excerpt

Approximately 40% of colorectal cancer (CRC) cases are characterized by KRAS mutations, rendering them insensitive to most CRC therapies. While the reasons for this resistance remain incompletely understood, one key aspect is genetic complexity: in CRC, oncogenic KRAS is most commonly paired with mutations that alter WNT and P53 activities (“RAP”). Here, we demonstrate that elevated WNT activity upregulates canoni...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b2344a21-c7bf-5d73-ad58-5f599cdf837d
DOI
10.1101/2023.12.21.572810
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
WNT Signalling Promotes NF-κB Activation and Drug Resistance in KRAS-Mutant Colorectal CancerDOI 10.1101/2023.12.21.572810
Select a neighboring publication to make it the new centre.